Koyfin Home > Directory > Health Care > Incyte Corp > Gross Margin

Incyte Corp Gross Margin Chart (INCY)

Incyte Corp annual/quarterly Gross Margin from 1995 to 2018. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Incyte Corp Gross Margin for the quarter ending December 12, 2018 was $37m a 57.32% increase of 21m year over year
  • Incyte Corp Gross Margin for the last 12 months ending December 12, 2018 was $31m a 49.65% increase of 16m year over year
  • Incyte Corp Annual Gross Margin for 2018 was $31m a 70.43% increase of 22m from 2017
  • Incyte Corp Annual Gross Margin for 2017 was $9m a -354.41% decrease of -33m from 2016
  • Incyte Corp Annual Gross Margin for 2016 was $42m a 22.11% increase of 9m from 2015
Other Margins & Efficiency Metrics:
  • Incyte Corp EBITDA Margin for the quarter ending December 12, 2018 was $19m a 163.50% increase of 32m year over year
  • Incyte Corp Return on Capital % for the quarter ending December 12, 2018 was 11.86 a 177.05% increase of 20.99 year over year
  • Incyte Corp Return on Equity % for the quarter ending December 12, 2018 was 14.82 a 168.16% increase of 24.92 year over year
View Chart On Koyfin

Quarterly INCY Gross Margin Data

12/2018$37m
09/2018$29m
06/2018$38m
03/2018$16m
12/2017$-6m
09/2017$27m
06/2017$32m
03/2017$-10m
12/2016$45m
09/2016$39m

Annual INCY Gross Margin Data

2018$31m
2017$9m
2016$42m
2015$33m
2014$31m
2013$26m
2012$29m
2011$-89m
2010$27m
2007$-205m